Skip to main content
FinSpry Logo
FinSpry
SNDX logo
SNDX
(NASDAQ)
Syndax Pharmaceuticals, Inc.
$20.56-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Syndax Pharmaceuticals (SNDX) Stock Price & Financial Analysis

Syndax Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$20.46 - $21.00
52-Week High$25.59
52-Week Low$12.99
Open$20.46
Volume1.36M
Average Volume (3M)1.36M
Market Cap1.81B
Shares Outstanding88.26M
Price to Sales (P/S)8.36
Price to Book (P/B)43.60
EV/EBITDA-12.08
Revenue (TTM)217.17M
Net Income (TTM)-243.25M
Free Cash Flow (TTM)-278.35M
EPS (TTM)$-2.80
Profit Margin-112.01%
Operating Margin-102.93%
Return on Equity (ROE)-584.42%
Debt to Equity8.28
50-Day MA$20.95
200-Day MA$20.97
52-Week Change20.66%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Syndax Pharmaceuticals

What is the current stock price for SNDX?

As of the latest trading session, SNDX stock trades at $20.56. The 52-week range is $12.99–$25.59, with a day range of $20.46–$21.00.

What is the P/E ratio for SNDX?

The P/E ratio (Price-to-Earnings) for SNDX is shown in the Key Statistics section. This valuation metric helps compare Syndax Pharmaceuticals, Inc. to industry peers.

Does SNDX pay dividends?

Syndax Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for SNDX?

Based on 3 analysts, the consensus for SNDX is Buy.

What is the market cap of SNDX?

Syndax Pharmaceuticals's market capitalization is $1.81B, classifying it as a small-cap company. Syndax Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.